Patent Assignment
Reel/Frame 075513/0291
Assignment of Assignor's Interest
Recorded: 2026-08-04
Pages: 9
Assignors
LEE, JIMIN
Executed: 2021-11-08
SLATKIN, NEAL
Executed: 2021-11-08
LOWE, EZRA R.
Executed: 2021-05-21
Assignee
BAUSCH HEALTH US, LLC
400 SOMERSET CORPORATE BLVD, BRIDGEWATER, NEW JERSEY, 08807
Covered Property
(1)
Amiselimod for Preventing, Treating or Ameliorating Ulcerative Colitis
Application:
18/276,120 →
Publication:
US US20240299318A1
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
Jan 14, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 069894/0976 →
Intellectual Property Security Agreement
Jan 14, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 069894/0985 →
Second Lien Intellectual Property Security Agreement
Jan 14, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 069895/0015 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
U.S. Patent Security Agreement
Nov 25, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0375 →
Assignment of Assignor's Interest
Aug 4, 2026
From: BAUSCH HEALTH US, LLC
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 075513/0497 →